Exyn Technologies: Alyeska reports 4.87% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Exyn Technologies, Inc. (EXYN) is the subject of an amended Schedule 13G reporting that Alyeska Investment Group, L.P., Alyeska Fund GP, LLC and Anand Parekh each beneficially own 387,000 common shares, or 4.87% of the class. Each reported shared voting and dispositive power over 387,000 shares and zero sole voting or dispositive power. The amendment identifies ownership of 5% or less.
Key Figures
Key Terms
Beneficially Owned regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.